No profile data available.
Cardinal Health, Inc. (CAH) is a healthcare company in the additional drug wholesale industry, based in Dublin, United States, with about 58,788 full-time employees.
It reported revenue of $254.25 billion for fiscal year 2026, up 14.2% from fiscal year 2025, and net income of $1.71 billion. Its largest business segment, Pharmaceutical Member, brought in 92% of segment revenue in fiscal year 2026; UNITED STATES was the largest region with 99%. Its market capitalization was $55.01 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended June 30, 2026; market data as of October 9, 2026.
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution.
Cardinal Health reported $254.25 billion in revenue for fiscal year 2026, up 14.2% from $222.58 billion in fiscal year 2025.
Pharmaceutical Member, with $234.83 billion or 92% of segment revenue in fiscal year 2026. Next: GMPD (5%) and Other Operating Segment (3%).
UNITED STATES: 99% of revenue by region in fiscal year 2026, followed by Non-US (1%).
$55.01 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (additional drug wholesale) include McKesson Corporation (MCK), Cencora, Inc. (COR), BrightSpring Health Services, Inc. (BTSG), Harrow, Inc. (HROW).